Settling Into the Current Deal Paradigm

Kathryn is a Member in the Business Department at McDonald Hopkins and part of the Firm’s Mergers and Acquisitions Practice Group. Her practice is focused on representing companies across a broad range of industries in various types of domestic and international transactions, including buyers and sellers in complex mergers and acquisitions, business restructurings, asset purchase and sale transactions, and equity purchase and sale transactions. Kathryn also represents companies and investors in venture capital and angel investment transactions and has extensive experience with M&A transactions in the government contracting and healthcare industries.

Parker is a Partner of Slate Capital Group, a private equity group focused on partnering with lower-middle market companies. Parker is engaged in all aspects of Slate, including business development, capital raising, portfolio company management, board representation, and investment realizations. Parker has been in private equity for over 20 years. Parker also spent six years in investment banking at Merrill Lynch in New York, where he was responsible for relationships with several client accounts and was directly involved in over 40 completed transactions with an aggregate value of over $30 billion, including public and private offerings of debt and equity, mergers, acquisitions, and advisory assignments.

Maria Martinkov, also known as Masha, is the Chief Strategy Executive at Venatôre and a member of the ISOA Board of Directors.

With extensive experience in international development and stabilization, she has led numerous multidisciplinary teams and oversaw the growth of large, global organizations.Maria's background includes managing projects worldwide, focusing on economic growth, global health security, data analytics, private sector engagement, transition, stabilization, and supply chain management. She has overseen companies securing over $1 billion in new awards and led successful transitions impacting thousands of people worldwide.

Maria is recognized as a respected executive and advocate for positive disruption within the government contracting industry. At Venatôre, she leads strategy development and implementation across various disciplines, including Enterprise Information Technology, Cyber Defense, Logistics, Training, and Engineering.

Maria's educational background includes an Executive MBA from George Washington University Elliott School of Business, an MA in International Relations from Kazakh State University of International Relations, a master’s Certificate in Government Contracting from George Washington University Law School, and a Certificate in Leadership from Harvard Business School. Masha shares her expertise as a former board member of the Professional Services Council and the Executive Advisory Board of the Council for International Development Companies.

Scott works with CEOs, CFOs, Boards, and Executive Leadership teams to optimize organizations, providing strategic guidance on due diligence, valuation, and post-transaction integration. With a hands-on leadership style, he drives global initiatives by aligning people, process, technology, and data to maximize efficiency and results.

Before joining SC&H in April 2024, Scott held leadership roles at EY, Deloitte, and MorganFranklin Consulting, where he advised clients on complex transactions, business transformation, and strategic growth initiatives. His experience spans industries and business functions, positioning him as a trusted advisor for organizations seeking to drive sustainable value.

Scott earned a Bachelor of Business Administration in Accounting from Ohio University and a Master of Science in Accounting and Accounting Information Systems from George Mason University. He is also a Certified Public Accountant (CPA).

Beyond his professional work, Scott serves on the Board of Directors for the National Capital Chapter of the Juvenile Diabetes Research Foundation (JDRF), supporting efforts to fund research and improve the lives of those affected by Type 1 diabetes.